Previous close | 418.99 |
Open | 420.40 |
Bid | 422.47 x 100 |
Ask | 423.02 x 100 |
Day's range | 417.50 - 423.32 |
52-week range | 320.01 - 448.40 |
Volume | |
Avg. volume | 1,042,100 |
Market cap | 109.1B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 27.42 |
EPS (TTM) | 15.42 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 466.90 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...